Furthermore, the binding of NETs to tumor cells can also induce tumor cells to acquire resistance to death as well as enhanced invasiveness by activating the TLR4/9-COX2 pathway, and the use of DNase I in combination with the anti-inflammatory drugs can effectively reduce hepatocellular carcinoma metastasis (33). The gene discussed is TLR4; the disease is neoplasm.